1-(2-Nitrobenzenesulfonyl)-4-[3-(trifluoromethyl)benzoyl]piperazine

Catalog No. :
ACKFRF867
CAS No. :
866152-62-7
Molecular Formula :
C18H16F3N3O5S
Molecular Weight :
443.40

IUPAC Name:(4-((2-nitrophenyl)sulfonyl)piperazin-1-yl)(3-(trifluoromethyl)phenyl)methanone

1-(2-Nitrobenzenesulfonyl)-4-[3-(trifluoromethyl)benzoyl]piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Nitrobenzenesulfonyl)-4-[3-(trifluoromethyl)benzoyl]piperazine
IUPAC Name(4-((2-nitrophenyl)sulfonyl)piperazin-1-yl)(3-(trifluoromethyl)phenyl)methanone
MDL No.MFCD00227563
Molecular FormulaC18H16F3N3O5S
Molecular Weight443.40
SMILESO=C(N1CCN(S(=O)(C2=CC=CC=C2[N+]([O-])=O)=O)CC1)C3=CC=CC(C(F)(F)F)=C3
InChI KeyPNGDHTOYBUDGJI-UHFFFAOYSA-N
Synonym1-(2-nitrobenzenesulfonyl)-4-[3-(trifluoromethyl)benzoyl]piperazine;Methanone, [4-[(2-nitrophenyl)sulfonyl]-1-piperazinyl][3-(trifluoromethyl)phenyl]-
CAS No.866152-62-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKFRF867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFRF867 route product structure diagram
    ACKFRF867866152-62-7
Inquiry

2. ACKFRF867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHTIW589 route compound structure diagram
    ACHTIW589454-92-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFRF867 route product structure diagram
    ACKFRF867866152-62-7
Inquiry

Comments (0)